BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
BillionToOne, Inc.NASDAQ: BLLN
Deferred Revenue · Q2 FY2026 · quarter ended Jun 2026
Deferred revenue rises 5.1% from a year ago
Deferred revenue stood at $2.33M at the end of Q2 FY2026, up 5.1% from a year earlier and down 16.7% from the prior quarter.
Context
- Deferred revenue amounted to 0.3% of total assets at the end of Q2 FY2026, down 0.4 pp from a year earlier.
- Deferred revenue increased in 0 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether deferred revenue keeps rising in the next quarterly balance sheet after a +5.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2025
- 2.19M USD
- Year-over-year change
- -22.0%
- 2-year CAGR
- -14.9%
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.19M | -22.0% |
| FY2024 | 2024-12-31 | 2.81M | -7.2% |
| FY2023 | 2023-12-31 | 3.02M | — |
Deferred Revenue vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 deferred revenue of $2.33M is the 4th highest of the 9 companies compared; the peer median is $298.5K.
- Its year-over-year change of +5.1% is the 2nd highest of 6, against a peer median of -58.8%.
- Deferred revenue amounts to 0.3% of total assets for BLLN, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $40.57M | +88.2% | +32.2% | 1.5% | |
| Sep 2026 | $38.1M | -18.7% | +42.9% | 2.0% | |
| Mar 2026 | $3.01M | -90.1% | +31.1% | 0.3% | |
BLLNBillionToOne, Inc. | Jun 2026 | $2.33M | +5.1% | — | 0.3% |
| Jun 2026 | $597K | -58.8% | -23.7% | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | -100.0% | — | 0.0% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $0 | — | — | 0.0% |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding BLLN) | $298.5K | -58.8% | +31.7% | 0.0% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.